Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Broadwin

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
International Journal of Molecular Sciences|February 11, 2023
Comparative Analysis of Normoxia- and Hypoxia-Modified Extracellular Vesicle Therapy in Function, Perfusion, and Collateralization in Chronically Ischemic MyocardiumSharif A Sabe, Cynthia M Xu, Brittany A Potz, et al.
International Journal of Molecular Sciences|March 13, 2025
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic SyndromeDwight D Harris, Mark Broadwin, Christopher Stone, et al.
JTCVS Open|January 11, 2024
Ischemic myocardial inflammatory signaling in starvation versus hypoxia-derived extracellular vesicles: A comparative analysisMohamed Sabra, Sharif A Sabe, Dwight D Harris, et al.
Surgery|November 8, 2023
Sodium-glucose co-transporter 2 inhibitor canagliflozin modulates myocardial metabolism and inflammation in a swine model for chronic myocardial ischemiaDwight D Harris, Sharif A Sabe, Cynthia M Xu, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 15, 2024
Effects of diet-induced metabolic syndrome on cardiac function and angiogenesis in response to the sodium-glucose cotransporter-2 inhibitor canagliflozinDwight D Harris, Mark Broadwin, Sharif A Sabe, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 21, 2023
Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesisDebolina Banerjee, Sharif A Sabe, Hang Xing, et al.
Journal of Molecular and Cellular Cardiology Plus|January 8, 2024
Effects of canagliflozin on myocardial microvascular density, oxidative stress, and proteomic profile<sup>☆</sup>Sharif A Sabe, Cynthia M Xu, Mohamed Sabra, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 20, 2024
Lab-grown, 3D extracellular matrix particles improve cardiac function and morphology in myocardial ischemiaMark Broadwin, Katerina St Angelo, Max Petersen, et al.
Journal of Alzheimer'S Disease : JAD|January 10, 2025
Impaired cerebral microvascular reactivity and endothelial SK channel activity in a streptozotocin-treated mouse model of Alzheimer's diseaseHang Xing, Shawn Kant, Meghamsh Kanuparthy, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
International Journal of Molecular Sciences|February 11, 2023
Comparative Analysis of Normoxia- and Hypoxia-Modified Extracellular Vesicle Therapy in Function, Perfusion, and Collateralization in Chronically Ischemic MyocardiumSharif A Sabe, Cynthia M Xu, Brittany A Potz, et al.
International Journal of Molecular Sciences|March 13, 2025
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic SyndromeDwight D Harris, Mark Broadwin, Christopher Stone, et al.
JTCVS Open|January 11, 2024
Ischemic myocardial inflammatory signaling in starvation versus hypoxia-derived extracellular vesicles: A comparative analysisMohamed Sabra, Sharif A Sabe, Dwight D Harris, et al.
Surgery|November 8, 2023
Sodium-glucose co-transporter 2 inhibitor canagliflozin modulates myocardial metabolism and inflammation in a swine model for chronic myocardial ischemiaDwight D Harris, Sharif A Sabe, Cynthia M Xu, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 15, 2024
Effects of diet-induced metabolic syndrome on cardiac function and angiogenesis in response to the sodium-glucose cotransporter-2 inhibitor canagliflozinDwight D Harris, Mark Broadwin, Sharif A Sabe, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 21, 2023
Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesisDebolina Banerjee, Sharif A Sabe, Hang Xing, et al.
Journal of Molecular and Cellular Cardiology Plus|January 8, 2024
Effects of canagliflozin on myocardial microvascular density, oxidative stress, and proteomic profile<sup>☆</sup>Sharif A Sabe, Cynthia M Xu, Mohamed Sabra, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 20, 2024
Lab-grown, 3D extracellular matrix particles improve cardiac function and morphology in myocardial ischemiaMark Broadwin, Katerina St Angelo, Max Petersen, et al.
Journal of Alzheimer'S Disease : JAD|January 10, 2025
Impaired cerebral microvascular reactivity and endothelial SK channel activity in a streptozotocin-treated mouse model of Alzheimer's diseaseHang Xing, Shawn Kant, Meghamsh Kanuparthy, et al.
Pageof 5